Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Fevertree (FEVR) Share Price

Price 854.50p on 11-08-2026 at 12:55:25
Change -5.00p -0.58%
Buy 856.00p
Sell 852.50p
Last Trade: Sell 32.00 at 853.68128p
Day's Volume: 67,177
Last Close: 859.50p
Open: 900.00p
ISIN: GB00BRJ9BJ26
Day's Range 851.50p - 900.00p
52wk Range: 711.00p - 973.00p
Market Capitalisation: £960.03m
VWAP: 858.30666p
Shares in Issue: 112.35m

Fevertree (FEVR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 32 853.68128p SI Trade
Suspected SELL Trade
13:55:00 - 11-Aug-26
Sell* 250 852.98p Ordinary
13:54:53 - 11-Aug-26
Buy* 31 854.50p Automatic Execution
13:52:04 - 11-Aug-26
Buy* 94 854.50p Automatic Execution
13:52:04 - 11-Aug-26
Buy* 88 854.50p Automatic Execution
13:52:04 - 11-Aug-26
Sell* 3 853.50p Automatic Execution
13:51:45 - 11-Aug-26
Sell* 176 853.50p Automatic Execution
13:51:45 - 11-Aug-26
Sell* 86 853.50p Automatic Execution
13:51:45 - 11-Aug-26
Buy* 95 855.00p Automatic Execution
13:48:07 - 11-Aug-26
Buy* 77 855.00p Automatic Execution
13:48:07 - 11-Aug-26
See more Fevertree trades

Fevertree (FEVR) Share Price History

Time period:
to
Date Open High Low Close Volume
10th Aug 2026 (Mon) 875.50 893.00 856.00 859.50 290,939
7th Aug 2026 (Fri) 882.50 890.00 873.00 882.00 230,660
6th Aug 2026 (Thu) 822.50 882.00 822.50 877.50 486,590
5th Aug 2026 (Wed) 845.00 860.50 845.00 855.00 307,360
4th Aug 2026 (Tue) 847.50 858.50 839.00 855.00 328,602
3rd Aug 2026 (Mon) 872.00 872.00 840.50 847.50 402,733
31st Jul 2026 (Fri) 853.00 875.00 853.00 862.00 275,447
30th Jul 2026 (Thu) 813.00 880.50 813.00 853.00 347,239
29th Jul 2026 (Wed) 848.00 857.50 842.50 853.00 176,973
28th Jul 2026 (Tue) 825.50 850.00 822.00 848.00 466,036
27th Jul 2026 (Mon) 812.50 830.50 812.50 819.50 184,376
24th Jul 2026 (Fri) 829.00 836.00 813.00 820.00 161,137
23rd Jul 2026 (Thu) 850.00 864.00 829.00 829.00 546,020
22nd Jul 2026 (Wed) 850.00 865.00 849.00 850.00 365,617
21st Jul 2026 (Tue) 820.00 858.00 812.00 853.50 840,251
20th Jul 2026 (Mon) 810.00 818.50 803.00 815.00 392,284
17th Jul 2026 (Fri) 806.00 825.00 806.00 812.50 244,776
16th Jul 2026 (Thu) 800.00 814.00 792.00 814.00 284,809
15th Jul 2026 (Wed) 785.00 800.00 776.00 798.50 281,963
14th Jul 2026 (Tue) 774.00 795.00 761.00 788.00 994,376
13th Jul 2026 (Mon) 780.00 783.00 767.00 774.00 243,366
See more Fevertree price history

Fevertree (FEVR) Regulatory News

Date Source Headline
4th Aug 2026 7:00 am RNS Transaction in Own Shares
3rd Aug 2026 7:00 am RNS Total Voting Rights
28th Jul 2026 7:00 am RNS Transaction in Own Shares
21st Jul 2026 7:00 am RNS Transaction in Own Shares
15th Jul 2026 7:00 am RNS Block Listing Return
14th Jul 2026 7:00 am RNS Transaction in Own Shares
7th Jul 2026 7:00 am RNS Transaction in Own Shares
1st Jul 2026 10:20 am RNS Total Voting Rights
1st Jul 2026 7:00 am RNS Update on share buyback extension
30th Jun 2026 9:42 am RNS Board Change
See more Fevertree regulatory news

Fevertree (FEVR) Share News

IN BRIEF: Fevertree Drinks starts GBP30 million buyback extension

1st Jul 2026 13:52

Fevertree Drinks PLC - London-based maker of premium drink mixers - Fevertree starts the GBP30 million extension of its share buyback programme, which it had announced at its annual general meeting last month. The new GBP30 million buyback follows a buyback of the same size completed earlier in the year. It begins on Wednesday and will be completed by December 31. It will be run by Investec Bank PLC. Read More

UK dividends calendar - next 7 days

19th Jun 2026 12:11

Read More

Fevertree Drinks extends share buyback after solid start to year

9th Jun 2026 11:26

(Alliance News) - Fevertree Drinks PLC on Tuesday announced a GBP30 million extension to its share buyback programme and said it remains confident of achieving full-year market expectations. Read More

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

9th Jun 2026 07:58

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Bellway reports an "increasingly challenging" housing market. Read More

UK shareholder meetings calendar - next 7 days

2nd Jun 2026 13:44

Read More

See more Fevertree news
FTSE 100 Latest
Value10,877.23
Change14.73

Login to your account

Forgot Password?

Not Registered